Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -41.25% | -5.12% | 239.16% | 0.43% | 134.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.74% | -7.75% | 209.15% | -7.79% | 131.28% |
| Operating Income | 39.74% | 7.75% | -209.15% | 7.79% | -131.28% |
| Income Before Tax | 35.70% | 21.14% | -172.65% | 10.39% | -39.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.70% | 21.14% | -172.65% | 10.39% | -39.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.70% | 21.14% | -172.65% | 10.39% | -39.90% |
| EBIT | 39.74% | 7.75% | -209.15% | 7.79% | -131.28% |
| EBITDA | 39.86% | 7.76% | -211.78% | 7.90% | -132.84% |
| EPS Basic | 38.46% | 20.00% | -150.00% | 0.00% | -44.44% |
| Normalized Basic EPS | 37.50% | 0.00% | -233.33% | 25.00% | -33.33% |
| EPS Diluted | 38.46% | 20.00% | -150.00% | 0.00% | -44.44% |
| Normalized Diluted EPS | 37.50% | 0.00% | -233.33% | 25.00% | -33.33% |
| Average Basic Shares Outstanding | 0.46% | 0.48% | 0.48% | 0.61% | 1.62% |
| Average Diluted Shares Outstanding | 0.46% | 0.48% | 0.48% | 0.61% | 1.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |